A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

NCT00968422 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ABT-384
DRUG: Matching placebo to ABT-384

Sponsor

Abbott